13 research outputs found
G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact
Truncated granulocyte colony-stimulating factor receptors (G-CSF-Rs) are
implicated in severe congenital neutropenia (SCN) and the consecutive
development of acute myeloid leukemia (AML). Mice expressing G-CSF-R
truncation mutants (gcsfr-d715) show defective receptor internalization,
an increased signal transducer and activator of transcription 5
(STAT5)/STAT3 activation ratio, and hyperproliferative responses to G-CSF
treatment. We determined whether a lack of negative feedback by suppressor
of cytokine signaling (SOCS) proteins contributes to the signaling
abnormalities of G-CSF-R-d715. Expression of SOCS3 transcripts in bone
marrow cells from G-CSF-treated gcsfr-d715 mice was approximately 60%
lower than in wild-type (WT) littermates. SOCS3 efficiently suppressed
STAT3 and STAT5 activation by WT G-CSF-R in luciferase reporter assays. In
contrast, while SOCS3 still inhibited STAT3 activation by G-CSF-R-d715,
STAT5 activation was no longer affected. This was due mainly to loss of
the SOCS3 recruitment site Tyr729, with an additional contribution of the
internalization defects of G-CSF-R-d715. Because Tyr729 is also a docking
site for the Src homology 2-containing protein tyrosine phosphatase-2
(SHP-2), which binds to and inactivates STAT5, we suggest a model in which
reduced SOCS3 expression, combined with the loss of recruitment of both
SOCS3 and SHP-2 to the activated receptor complex, determine the increased
STAT5/STAT3 activation ratio and the resulting signaling abnormalities
projected by truncated G-CSF-R mutants
Novel Point Mutation in the Extracellular Domain of the Granulocyte Colony-Stimulating Factor (G-Csf) Receptor in a Case of Severe Congenital Neutropenia Hyporesponsive to G-Csf Treatment
Severe congenital neutropenia (SCN) is a heterogeneous condition characterized by a drastic reduction in circulating neutrophils and a maturation arrest of myeloid progenitor cells in the bone marrow. Usually this condition can be successfully treated with granulocyte colony-stimulating factor (G-CSF). Here we describe the identification of a novel point mutation in the extracellular domain of the G-CSF receptor (G-CSF-R) in an SCN patient who failed to respond to G-CSF treatment. When this mutant G-CSF-R was expressed in myeloid cells, it was defective in both proliferation and survival signaling. This correlated with diminished activation of the receptor complex as determined by signal transducer and activator of transcription (STAT) activation, although activation of STAT5 was more affected than STAT3. Interestingly, the mutant receptor showed normal affinity for ligand, but a reduced number of ligand binding sites compared with the wild-type receptor. This suggests that the mutation in the extracellular domain affects ligand–receptor complex formation with severe consequences for intracellular signal transduction. Together these data add to our understanding of the mechanisms of cytokine receptor signaling, emphasize the role of GCSFR mutations in the etiology of SCN, and implicate such mutations in G-CSF hyporesponsiveness
Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment
Severe congenital neutropenia (SCN) is a heterogeneous condition
characterized by a drastic reduction in circulating neutrophils and a
maturation arrest of myeloid progenitor cells in the bone marrow. Usually
this condition can be successfully treated with granulocyte
colony-stimulating factor (G-CSF). Here we describe the identification of
a novel point mutation in the extracellular domain of the G-CSF receptor
(G-CSF-R) in an SCN patient who failed to respond to G-CSF treatment. When
this mutant G-CSF-R was expressed in myeloid cells, it was defective in
both proliferation and survival signaling. This correlated with diminished
activation of the receptor complex as determined by signal transducer and
activator of transcription (STAT) activation, although activation of STAT5
was more affected than STAT3. Interestingly, the mutant receptor showed
normal affinity for ligand, but a reduced number of ligand binding sites
compared with the wild-type receptor. This suggests that the mutation in
the extracellular domain affects ligand-receptor complex formation with
severe consequences for intracellular signal transduction. Together these
data add to our understanding of the mechanisms of cytokine receptor
signaling, emphasize the role of GCSFR mutations in the etiology of SCN,
and implicate such mutations in G-CSF hyporesponsiveness
Recommended from our members
Turning Research into Action: Building and Sustaining Open Education through the OER in Texas Playbook
In 2019 and 2021, the THECB partnered with ISKME and DigiTex to conduct surveys and landscape analyses of OER in Texas higher education. The data collected surfaced numerous insights, including that the institutions most advanced in their open education policies and practices provide comprehensive, systems-based supports for OER by engaging multiple offices and roles across campus. Given this, one of the recommendations in the 2021 report included creating a state OER Playbook to support institutions as they work to build capacity and drive systems change around OER.
Together, the THECB and ISKME, with support from a statewide Advisory Committee, developed the OER in Texas Playbook, which has two primary objectives:
Outline the steps needed to implement the change management inherent in an institutional shift to OER.
Provide resources for the localization and contextualization for each of the Texas institutions that choose to take part in [a] Playbook Development Academy.
In this session, geared toward all levels of expertise, presenters from ISKME and the THECB will discuss the research-based genesis of the playbook and its development process and give a quick tour of the guide. Attendees will have the opportunity to ask questions and consider ways to adapt the openly licensed resource for their own contexts
The gene encoding thioredoxin-interacting protein (TXNIP) is a frequent virus integration site in virus-induced mouse leukemia and is overexpressed in a subset of AML patients
Thioredoxin-interacting protein (TXNIP) is involved in reactive oxygen species-induced stress responses. In a screen for novel disease genes in murine leukemia virus (MLV)-induced mouse leukemias, we identified Txnip as a frequent target for proviral integration. Ectopic TXNIP expression inhibited the proliferation of myeloid progenitor cells. TXNIP transcript and protein levels were significantly elevated in human AML blasts of certain patients, particularly those harboring translocation t(8;21). Nucleotide sequencing revealed no abnormalities in the TXNIP coding region in AML. These findings suggest that deregulated TXNIP expression contributes to MLV-induced murine leukemia as well as human AML.</p
The gene encoding thioredoxin-interacting protein (TXNIP) is a frequent virus integration site in virus-induced mouse leukemia and is overexpressed in a subset of AML patients
Thioredoxin-interacting protein (TXNIP) is involved in reactive oxygen species-induced stress responses. In a screen for novel disease genes in murine leukemia virus (MLV)-induced mouse leukemias, we identified Txnip as a frequent target for proviral integration. Ectopic TXNIP expression inhibited the proliferation of myeloid progenitor cells. TXNIP transcript and protein levels were significantly elevated in human AML blasts of certain patients, particularly those harboring translocation t(8;21). Nucleotide sequencing revealed no abnormalities in the TXNIP coding region in AML. These findings suggest that deregulated TXNIP expression contributes to MLV-induced murine leukemia as well as human AML.</p
Peroxiredoxin-controlled G-CSF signalling at the endoplasmic reticulum-early endosome interface
Reactive oxygen species (ROS) regulate growth factor receptor signalling at least in part by inhibiting oxidation-sensitive phosphatases. An emerging concept is that ROS act locally to affect signal transduction in different subcellular compartments and that ROS levels are regulated by antioxidant proteins at the same local level. Here, we show that the ER-resident antioxidant peroxiredoxin 4 (Prdx4) interacts with the cytoplasmic domain of the granulocyte colony-stimulating factor receptor (G-CSFR). This interaction occurs when the activated G-CSFR resides in early endosomes. Prdx4 inhibits G-CSF-induced signalling and proliferation in myeloid progenitors, depending on its redox-active cysteine core. Protein tyrosine phosphatase 1b (Ptp1b) appears to be a major downstream effector controlling these responses. Conversely, Ptp1b might keep Prdx4 active by reducing its phosphorylation. These findings unveil a new signal transduction regulatory circuitry involving redox-controlled processes in the ER and activated cytokine receptors in endosomes
Essential Role for Cyclin D3 in Granulocyte Colony-Stimulating Factor-Driven Expansion of Neutrophil Granulocytes
The proliferation of neutrophil granulocyte lineage is driven largely by granulocyte colony-stimulating factor (G-CSF) acting via the G-CSF receptors. In this study, we show that mice lacking cyclin D3, a component of the core cell cycle machinery, are refractory to stimulation by the G-CSF. Consequently, cyclin D3-null mice display deficient maturation of granulocytes in the bone marrow and have reduced levels of neutrophil granulocytes in their peripheral blood. The mutant mice are unable to mount a normal response to bacterial challenge and succumb to microbial infections. In contrast, the expansion of hematopoietic stem cells and lineage-committed myeloid progenitors proceeds relatively normally in mice lacking cyclin D3, revealing that the requirement for cyclin D3 function operates at later stages of neutrophil development. Importantly, we verified that this requirement is specific to cyclin D3, as mice lacking other G(1) cyclins (D1, D2, E1, or E2) display normal granulocyte counts. Our analyses revealed that in the bone marrow cells of wild-type mice, activation of the G-CSF receptor leads to upregulation of cyclin D3. Collectively, these results demonstrate that cyclin D3 is an essential cell cycle recipient of G-CSF signaling, and they provide a molecular link of how G-CSF-dependent signaling triggers cell proliferation